Journal of Viral Hepatitis

Cover image for Vol. 10 Issue 3

May 2003

Volume 10, Issue 3

Pages 157–239

  1. Review Article

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Short Communications
    1. Who should receive hepatitis A vaccine? (pages 157–158)

      V. A. Arankalle and M. S. Chadha

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00422.x

  2. Original Articles

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Short Communications
    1. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection (pages 159–167)

      T. J. Tang, J. Kwekkeboom, J. D. Laman, H. G. M. Niesters, P. E. Zondervan, R. A. de Man, S. W. Schalm and H. L. A. Janssen

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00412.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares (pages 168–173)

      P. Ciccorossi, F. Filipponi, F. Oliveri, D. Campani, P. Colombatto, F. Bonino, M. Campa, G. Maltinti, F. Mosca and M. R. Brunetto

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00425.x

      • image
      • image
    3. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage (pages 183–188)

      M. A. Serra, F. Rodríguez, J. A. Del Olmo, A. Escudero and J. M. Rodrigo

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00372.x

      • image
      • image
      • image
      • image
    4. A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1 (pages 189–196)

      N. C Tassopoulos, D. Tsantoulas, M. Raptopoulou, T. Vassiliadis, S. Kanatakis, E. Paraskevas, I. Vafiadis, A. Avgerinos, C. Tzathas, S. Manolakopoulos, I. Ketikoglou, P. Aggelis, K. Goritsas, G. Giannoulis, G. Hatzis G, K. Thomopoulos, E. Akriviadis, V. Sypsa and A. Hatzakis

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00406.x

      • image
    5. Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial (pages 197–204)

      T. Poynard, P. Marcellin, A. Bissery, R. P. Myers, J. Moussalli, F. Degos, D. Dhumeaux, G. Riachi, J. P. Bronowicki, P. Brissot, C. Buffet, L. Serfaty, S. Naveau, P. Sogni, M. Beaugrand, S. Gayno, D. Larrey, D. Samuel, C. Eugene, S. Pol, P. Bedossa, V. Daurat, P. Chaumet-Riffaud and for the multicenter GER-CYT-RIBANON group

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00427.x

      • image
    6. High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy (pages 205–209)

      J. M. Vrolijk, F. C. Bekkering, J. T. Brouwer, B. E. Hansen and S. W. Schalm

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00408.x

      • image
      • image
      • image
    7. Interferon α in the treatment of chronic hepatitis C in children: a metanalysis (pages 210–214)

      V. Di Ciommo, P. Russo, L. Ravà and L. Caprino

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00420.x

    8. Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study (pages 215–223)

      I. Portal, M. Bourlière, P. Halfon, V. De Lédinghen, P. Couzigou, P. H. Bernard, F. Blanc, F. Caroli-Bosc, J. P. Arpurt, D. Vetter, C. Mathieu-Chandelier, O. Chazouillères, G. Thiefin, S. Pol, P. Sogni, A. Abergel, F. Bailly, M. Picon, J. M. Debonne, C. Zamora, I. Alleman, X. Moreau, F. Doll, C. Eugène, S. Ducloux, D. Larrey, D. Ouzan, J. C. Grimaud, J. Gouvernet, G. Botti, V. Gérolami, H. Khiri, A. Gérolami, A. P. Gauthier and D. Botta-Fridlund

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00426.x

      • image
    9. Aetiology and prognostic factors in acute liver failure in India (pages 224–231)

      M. S. Khuroo and S. Kamili

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00415.x

  3. Short Communications

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Short Communications
    1. Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules (pages 234–239)

      G. F. Tallis, G. M. Ryan, S. B. Lambert, D. S. Bowden, R. McCaw, C. J. Birch, M. Moloney, J. A. Carnie, S. A. Locarnini, G. J. Rouch and M. G. Catton

      Version of Record online: 28 APR 2003 | DOI: 10.1046/j.1365-2893.2003.00424.x

      • image
      • image

SEARCH

SEARCH BY CITATION